HRTX
Heron Therapeuti
0.3582$
-6.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -487.6% | – | – | -449.5% | – | – | – | -790.0% | – | – | – | |
| – | -1.7% | -3.6% | -7.0% | +49.5% | -39.4% | -5.2% | +10.9% | +0.7% | -12.7% | -1.5% | -14.6% | – | |
| – | -35.3% | -21.9% | +35.4% | -40.4% | -15.7% | +9.4% | +11.4% | +2.0% | -23.6% | +36.6% | +6.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.5% | -220.1% | – | – | -527.4% | – | – | – | -349.1% | – | -114.4% | – | |
| – | -68.5% | -100.0% | – | -32.3% | +48.0% | -82.9% | +90.8% | -100.0% | – | – | -64.7% | – | |
| – | -61.9% | – | +60.3% | +93.8% | +187.6% | -80.1% | +222.7% | +61.7% | -146.0% | -82.8% | +247.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | +180.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.6% | -94.5% | +4,372.7% | -97.2% | +2,921.4% | -84.9% | +1,120.3% | +1,611.0% | -98.4% | -123.3% | – | – | |
| – | -128.9% | – | – | – | -99.2% | -10,809.8% | – | – | -154.3% | – | – | – | |
| – | – | -531.6% | – | – | -522.4% | – | – | – | -790.0% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.